The impact of multimorbidity and functional limitation on quality of life in patients with heart failure: A multi-site study.
functional limitation
heart failure
multimorbidity
quality of life
Journal
Journal of the American Geriatrics Society
ISSN: 1532-5415
Titre abrégé: J Am Geriatr Soc
Pays: United States
ID NLM: 7503062
Informations de publication
Date de publication:
18 Apr 2024
18 Apr 2024
Historique:
revised:
14
03
2024
received:
22
12
2023
accepted:
24
03
2024
medline:
18
4
2024
pubmed:
18
4
2024
entrez:
18
4
2024
Statut:
aheadofprint
Résumé
Multimorbidity and functional limitation are associated with poor outcomes in heart failure (HF). However, the individual and combined effect of these on health-related quality of life in patients with HF is not well understood. Patients aged ≥30 years with two or more HF diagnostic codes and one or more HF-related prescription drugs from four U.S. institutions were mailed a survey to measure patient-centric factors including functional status (activities of daily living [ADLs]) and health-related quality of life (PROMIS-29 Health Profile). Patients with HF from January 1, 2013 to February 1, 2018 were included. Multimorbidity was defined as ≥2 non-cardiovascular comorbidities; functional limitation as any limitation in at least one of eight ADLs. Patients were categorized into four groups by multimorbidity (Yes/No) and functional limitation (Yes/No). We dichotomized the PROMIS-29 sub-scale scores at the median and calculated odd ratios for the four multimorbidity/functional limitation groups. A total of 3330 patients with HF returned the survey (response rate 31%); 3020 completed the questions of interest and were retained. Among these patients (45% female; mean age 73 [standard deviation: 12] years), 29% had neither multimorbidity nor functional limitation, 24% had multimorbidity only, 22% had functional limitation only, and 25% had both. After adjustment, having functional limitation only was associated with higher anxiety (odds ratio [OR]: 3.44, 95% confidence interval [CI]: 2.66-4.45), depression (OR: 3.11, 95% CI: 2.39-4.06), and fatigue (OR: 4.19, 95% CI: 3.25-5.40); worse sleep (OR: 2.14, 95% CI: 1.69-2.72) and pain (OR: 6.73, 95% CI: 5.15-8.78); and greater difficulty with social activities (OR: 9.40, 95% CI: 7.19-12.28) compared with having neither. Results were similar for having both multimorbidity and functional limitation. Patients with only functional limitation have similar poor health-related quality of life scores as those with both multimorbidity and functional limitation, underscoring the important role that physical functioning plays in the well-being of patients with HF.
Sections du résumé
BACKGROUND
BACKGROUND
Multimorbidity and functional limitation are associated with poor outcomes in heart failure (HF). However, the individual and combined effect of these on health-related quality of life in patients with HF is not well understood.
METHODS
METHODS
Patients aged ≥30 years with two or more HF diagnostic codes and one or more HF-related prescription drugs from four U.S. institutions were mailed a survey to measure patient-centric factors including functional status (activities of daily living [ADLs]) and health-related quality of life (PROMIS-29 Health Profile). Patients with HF from January 1, 2013 to February 1, 2018 were included. Multimorbidity was defined as ≥2 non-cardiovascular comorbidities; functional limitation as any limitation in at least one of eight ADLs. Patients were categorized into four groups by multimorbidity (Yes/No) and functional limitation (Yes/No). We dichotomized the PROMIS-29 sub-scale scores at the median and calculated odd ratios for the four multimorbidity/functional limitation groups.
RESULTS
RESULTS
A total of 3330 patients with HF returned the survey (response rate 31%); 3020 completed the questions of interest and were retained. Among these patients (45% female; mean age 73 [standard deviation: 12] years), 29% had neither multimorbidity nor functional limitation, 24% had multimorbidity only, 22% had functional limitation only, and 25% had both. After adjustment, having functional limitation only was associated with higher anxiety (odds ratio [OR]: 3.44, 95% confidence interval [CI]: 2.66-4.45), depression (OR: 3.11, 95% CI: 2.39-4.06), and fatigue (OR: 4.19, 95% CI: 3.25-5.40); worse sleep (OR: 2.14, 95% CI: 1.69-2.72) and pain (OR: 6.73, 95% CI: 5.15-8.78); and greater difficulty with social activities (OR: 9.40, 95% CI: 7.19-12.28) compared with having neither. Results were similar for having both multimorbidity and functional limitation.
CONCLUSION
CONCLUSIONS
Patients with only functional limitation have similar poor health-related quality of life scores as those with both multimorbidity and functional limitation, underscoring the important role that physical functioning plays in the well-being of patients with HF.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NHLBI NIH HHS
ID : R01 HL120859
Pays : United States
Informations de copyright
© 2024 The American Geriatrics Society.
Références
Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics‐2023 update: a report from the American Heart Association. Circulation. 2023;147(8):e93‐e621.
Chamberlain AM, St Sauver JL, Gerber Y, et al. Multimorbidity in heart failure: a community perspective. Am J Med. 2015;128(1):38‐45.
Ahluwalia SC, Gross CP, Chaudhry SI, et al. Impact of comorbidity on mortality among older persons with advanced heart failure. J Gen Intern Med. 2012;27(5):513‐519.
Wong CY, Chaudhry SI, Desai MM, Krumholz HM. Trends in comorbidity, disability, and polypharmacy in heart failure. Am J Med. 2011;124(2):136‐143.
Saczynski JS, Go AS, Magid DJ, et al. Patterns of comorbidity in older adults with heart failure: the Cardiovascular Research Network PRESERVE study. J Am Geriatr Soc. 2013;61(1):26‐33.
Braunstein JB, Anderson GF, Gerstenblith G, et al. Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J Am Coll Cardiol. 2003;42(7):1226‐1233.
Mentz RJ, Kelly JP, von Lueder TG, et al. Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction. J Am Coll Cardiol. 2014;64(21):2281‐2293.
Manemann SM, Chamberlain AM, Boyd CM, et al. Multimorbidity in heart failure: effect on outcomes. J Am Geriatr Soc. 2016;64(7):1469‐1474.
Manemann SM, Chamberlain AM, Roger VL, et al. Multimorbidity and functional limitation in individuals with heart failure: a prospective community study. J Am Geriatr Soc. 2018;66(6):1101‐1107.
Chamberlain AM, Rutten LJF, Jacobson DJ, et al. Multimorbidity, functional limitations, and outcomes: interactions in a population‐based cohort of older adults. J Comorb. 2019;9:92235042X19873486.
Dunlay SM, Manemann SM, Chamberlain AM, et al. Activities of daily living and outcomes in heart failure. Circ Heart Fail. 2015;8(2):261‐267.
Chamberlain AM, McNallan SM, Dunlay SM, et al. Physical health status measures predict all‐cause mortality in patients with heart failure. Circ Heart Fail. 2013;6(4):669‐675.
Murad K, Goff DC Jr, Morgan TM, et al. Burden of comorbidities and functional and cognitive impairments in elderly patients at the initial diagnosis of heart failure and their impact on total mortality: the Cardiovascular Health Study. JACC Heart Fail. 2015;3(7):542‐550.
Hayes SL, Salzberg CA, McCarthy D, et al. High‐need, high‐cost patients: who are they and how do they use health care? A population‐based comparison of demographics, health care use, and expenditures. Issue Brief (Commonw Fund). 2016;26:1‐14.
Somech J, Joshi A, Mancini R, et al. Comparison of questionnaire and performance‐based physical frailty scales to predict survival and health‐related quality of life in patients with heart failure. J Am Heart Assoc. 2023;12(6):e026951.
Makovski TT, Schmitz S, Zeegers MP, Stranges S, van den Akker M. Multimorbidity and quality of life: systematic literature review and meta‐analysis. Ageing Res Rev. 2019;53:100903.
Kanesarajah J, Waller M, Whitty JA, Mishra GD. Multimorbidity and quality of life at mid‐life: a systematic review of general population studies. Maturitas. 2018;109:53‐62.
Read JR, Sharpe L, Modini M, Dear BF. Multimorbidity and depression: a systematic review and meta‐analysis. J Affect Disord. 2017;221:36‐46.
Chamberlain AM, Hade EM, Haller IV, et al. A large, multi‐center survey assessing health, social support, literacy, and self‐management resources in patients with heart failure. BMC Public Health. 2024. (In press).
PCORnet Common Data Model (CDM). Accessed October 24, 2023. https://pcornet.org/pcornet-common-data-model/
Fleurence RL, Curtis LH, Califf RM, Platt R, Selby JV, Brown JS. Launching PCORnet, a national patient‐centered clinical research network. J Am Med Inform Assoc. 2014;21(4):578‐582.
Qualls LG, Phillips TA, Hammill BG, et al. Evaluating foundational data quality in the National Patient‐Centered Clinical Research Network (PCORnet(R)). EGEMS (Wash DC). 2018;6(1):3.
Tison GH, Chamberlain AM, Pletcher MJ, et al. Identifying heart failure using EMR‐based algorithms. Int J Med Inform. 2018;120:1‐7.
Goodman RA, Posner SF, Huang ES, Parekh AK, Koh HK. Defining and measuring chronic conditions: imperatives for research, policy, program, and practice. Prev Chronic Dis. 2013;10:E66.
US Department of Health and Human Services. Multiple Chronic Conditions – A Strategic Framework: Optimum Health and Quality of Life for Individuals with Multiple Chronic Conditions. U.S. Department of Health and Human Services. 2010. https://www.hhs.gov/sites/default/files/ash/initiatives/mcc/mcc_framework.pdf
Dunlay SM, Redfield MM, Weston SA, et al. Hospitalizations after heart failure diagnosis a community perspective. J Am Coll Cardiol. 2009;54(18):1695‐1702.
Henkel DM, Redfield MM, Weston SA, Gerber Y, Roger VL. Death in heart failure: a community perspective. Circ Heart Fail. 2008;1(2):91‐97.
Cella D, Choi SW, Condon DM, et al. PROMIS((R)) Adult Health Profiles: efficient short‐form measures of seven health domains. Value Health. 2019;22(5):537‐544.
Hays RD, Spritzer KL, Schalet BD, Cella D. PROMIS((R))‐29 v2.0 profile physical and mental health summary scores. Qual Life Res. 2018;27(7):1885‐1891.
Hahn EA, DeWalt DA, Bode RK, et al. New English and Spanish social health measures will facilitate evaluating health determinants. Health Psychol. 2014;33(5):490‐499.
Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146‐M156.
Malmstrom TK, Morley JE. SARC‐F: a simple questionnaire to rapidly diagnose sarcopenia. J Am Med Dir Assoc. 2013;14(8):531‐532.
Treacy D, Hassett L. The short physical performance battery. J Physiother. 2018;64(1):61.
Anderson L, Oldridge N, Thompson DR, et al. Exercise‐based cardiac rehabilitation for coronary heart disease: Cochrane systematic review and meta‐analysis. J Am Coll Cardiol. 2016;67(1):1‐12.
O'Connor CM, Whellan DJ, Lee KL, et al. Efficacy and safety of exercise training in patients with chronic heart failure: HF‐ACTION randomized controlled trial. JAMA. 2009;301(14):1439‐1450.
Taylor RS, Sagar VA, Davies EJ, et al. Exercise‐based rehabilitation for heart failure. Cochrane Database Syst Rev. 2014;2014(4):CD003331.
Bell SP, Orr NM, Dodson JA, et al. What to expect from the evolving field of geriatric cardiology. J Am Coll Cardiol. 2015;66(11):1286‐1299.